Beyond The Pill Market
A prominent research firm, Cognizance Market Research added a cutting-edge industry report on "Beyond The Pill Market". The report studies the current as well as past growth trends and opportunities for the market to gain valuable insights during the forecast period from 2023 to 2030.
Beyond The Pill Market Analysis
According to cognizance market research the beyond the pill market is expected to register a CAGR of 11.3% from 2023 to 2030.
What is Beyond the Pill?
Beyond-the-pill services are a comprehensive package of integrated goods and services that cover all aspects of patient care while incorporating patients, caretakers, and service providers in addition to pharmaceutical firms. These services are add-ons to pharmaceutical or therapeutic products that are used for patient care and are also viewed as a source of competitive advantages among the major pharmaceutical and therapeutical global players. Physicians, regulators, and payers—the three parties with a stake in the customer experience—actively affect the market's expansion and demand for services.
Healthcare industry is far beyond simple diagnosis and pharmaceutical treatment. Increasing demand for the fluid healthcare services that enhances the effects of the drugs and therapeutic procedures is anticipated to drive the growth of the global beyond the pill market.
Beyond The Pill Market Outlook
In the beyond the pill report, the market outlook segment mainly includes important dynamics of the market which include drivers, restraints, opportunities and challenges tackled by the industry. Opportunities and challenges are extrinsic factors whereas, drivers and restraints are intrinsic factors of the market.
In the forecast years 2023-2030, the global market for beyond the pills is anticipated to rise strongly with an excellent CAGR due to rising consumer demand for efficient healthcare systems and simple patient care. The healthcare industry spans much beyond straightforward diagnoses and prescription medication. In the next five years, it is projected that there will be a rise in the demand for fluid healthcare services that improve the effects of prescription medications and therapeutic procedures.
The extended provision of therapeutics and personalised medicine, along with the added benefits of personalised medicine that allow for patient-specific disease diagnosis and detection, further enhance the market's growth prospects over the next five years. Digitalization is driving the global beyond the pill market, with value added services such as monitoring devices, monitoring services, pharmaceutical management services, maintenance, education and information provision. Chronic diseases are a major factor influencing healthcare sector growth, with 75% of healthcare expenses in the US being spent on chronic diseases diagnosis and treatment. Remote monitoring devices and services, smart phone applications, and location based healthcare services are key to the future growth of the global beyond the pill market.
The beyond the pill market has been segmented into therapeutic area, offerings and geography. Based on type, the beyond the pill market is further segmented into diabetes, oncology, cardiovascular diseases, asthma and others. Among the mentioned segments, the oncology segment leads the market due to rising prevalence of cancer around the world due to rising alcohol and tobacco use. Based on offerings, the beyond the pill market is bifurcated into services, monitoring, assistance, information and education. The monitoring segment holds a dominant position in beyond the pill market owing to increasing prevalence of diseases such as diabetes, stroke and renal disease which requires patient monitoring.
Based on geography the beyond the pill market has been segmented into five main regions namely, North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. The North American beyond the pills market is anticipated to soon have the biggest revenue market share. Given the number of participants and ongoing technological advancements in the region's healthcare sector, the trend is anticipated to continue. The biggest market share can be attributed to projections for healthcare expenditures, FDA and other certifications for goods based on pill technology, and increased government and other agency investments. Asia Pacific is also anticipated to expand quickly. This is because many diseases are being diagnosed more accurately because of advancements in technology.
The report offers the revenue of the beyond the pill market for the period 2020-2030, considering 2020 & 2021 as a historical year, 2022 as the base year and 2023 to 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the beyond the pill market for the forecast period. The beyond the pill market report provides insights and in-depth analysis into developments impacting enterprises and businesses on a regional and global level. The report covers the beyond the pill market performance in terms of revenue contribution from several segments and comprises a detailed analysis of key drivers, trends, restraints, and opportunities prompting revenue growth of the beyond the pill market.
The report has been prepared after wide-ranging secondary and primary research. Secondary research included internet sources, numerical data from government organizations, trade associations, and websites. Analysts have also employed an amalgamation of bottom-up and top-down approaches to study numerous phenomena in the beyond the pill market. Secondary research involved a detailed analysis of significant players’ product portfolio. Literature review, press releases, annual reports, white paper, and relevant documents have been also studied to understand the beyond the pill market. Primary research involved a great extent of research efforts, wherein experts carried out interviews telephonic as well as questioner-based with industry experts and opinion-makers.
The report includes an executive summary, along with a growth pattern of different segmented included in the scope of the study. The Y-o-Y analysis with elaborate market insights has been provided in the report to comprehend the Y-o-Y trends in the beyond the pill market. Additionally, the report focuses on altering competitive dynamics in the global market. These indices serve as valued tools for present market players as well as for companies interested in participating in the beyond the pill market. The subsequent section of the beyond the pill report highlights the USPs, which include key industry events (Type launch, research partnership, acquisition, etc.), technology advancements, pipeline analysis, prevalence data, and regulatory scenario.
Beyond The Pill Market Competitive Landscape
The “Beyond the Pill Market” study report will provide a valuable insight with an emphasis on global market. Some of the major players competing in beyond the pill market include
- Amgen, Inc.
- AstraZeneca Plc.
- Eli Lilly and Company
- Johnson & Johnson
- Novartis AG
- Novo Nordisk A/S
- Otsuka Pharmaceuticals Co., Ltd.
- Sanofi S.A.
- Teva Pharmaceutical Industries Ltd.,
- Hoffmann-La Roche AG (Flatiron Health)
Eli Lilly and Company established significant international alliances with DexCom, Inc., Glooko, Inc., myDiabby Healthcare, and Roche in May 2021 to advance connected solutions and speed up diabetes care in foreign markets. To assist people with diabetes and medical professionals, these businesses offer diabetes management tools compatible with Lilly's Tempo PenTM (approved in several international markets) and Tempo Smart ButtonTM (currently in late-stage development).
The report explores the competitive scenario of the beyond the pill market. Major players operating in the beyond the pill market have been identified and profiled for unique commercial attributes. Company overview (company description, Type portfolio, geographic presence, employee strength, Key management, etc.), financials, SWOT analysis, recent developments, and key strategies are some of the features of companies profiled in the beyond the pill market report.
Beyond The Pill Market, By Therapeutic Area
- Cardiovascular Diseases
Beyond The Pill Market, By Offerings
Beyond The Pill Market, By Region
- North America
- Rest of Europe
- Asia Pacific
- Australia & New Zealand
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa